[ad_1]
As of July 1, a new treatment for chronic hepatitis C with the drug Vosevi will be reimbursed by the basic health insurance. Minister Bruno Bruins (Medical Care) decided after negotiations with the manufacturer on the price of the new drug. Tens to hundreds of patients benefit. Chronic hepatitis C is a disease that often causes only complaints after years, such as cirrhosis of the liver and, in a small proportion, liver cancer.
According to the Ministry of Health, it is the eighth negotiation successfully negotiated. of a medicine for this disease. A 12-week treatment with Vosevi cost originally 51,000 euros. According to the Ministry, these costs are now lower, but VWS can not say how much "because of the confidentiality of the agreements with the supplier"
In 2015 and 2016, the price negotiations with the pharmaceutical companies have allowed a total saving of 155 million euros. The results for 2017 will be announced later this year. (ANP)
Source link
